Tuesday, April 28, 2026

New Genetic Link Revealed: Why Autism Spectrum Disorder Affects Males More Than Females

Researchers at DGIST identify a genetic mutation linked to autism, revealing why it's more common in males and potential treatments.

Kim Says “Abandon Hope” North Korea Warns Japan That All Negotiations Are Dead

North Korea criticizes Japan's PM Takaichi, viewing her as insincere in improving relations, while Japan seeks U.S. cooperation for dialogue.

LE SSERAFIM’s ‘HOT’ Heats Up the Charts – No. 9 on Billboard 200!

K-pop girl group LE SSERAFIM has made its entry into the US Billboard main album chart, marking a significant achievement.

Tag: Alteogen

Alteogen and Biogen: A Game-Changing 200 Million USD License Deal for ALT-B4 Biopharmaceuticals

Alteogen partners with Biogen for exclusive licensing of subcutaneous biopharmaceuticals, potentially earning up to 549 million USD.

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

Top News

- Our Sponsors Ad -

Follow us